Cooley advised Ionis Pharmaceuticals on the offering. Ionis Pharmaceuticals, a biotechnology company, announced the offering of $575 million aggregate principal amount of convertible senior notes, including the exercise...
Ionis Pharmaceuticals’ $575 Million Convertible Senior Notes Offering
AstraZeneca’s Acquisition of CinCor Pharma
Covington & Burling advised AstraZeneca. Skadden represented Centerview Partners LLC, the exclusive financial advisor to CinCor Pharma Inc. Cooley advised CinCor Pharma. CinCor Pharma Inc. (“CinCor”)...